Dan Oliver, cofounder and chief executive officer, Rejuvenate Bio, discussed the advantages of developing gene therapies for both dogs and humans.
Dan Oliver
Advertisement
Cofounder and chief executive officer, Rejuvenate Bio
Articles by Dan Oliver
Dan Oliver, cofounder and chief executive officer, Rejuvenate Bio, discussed the company’s ultimate goal of reversing aging.
Advertisement
Latest Updated Articles
Advantages of Concurrently Investigating Gene Therapies in Dogs and HumansPublished: November 30th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
